Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Bevacizumab Plus DOF in Locally Advanced Gastric Carcinoma
NCT02048540Phase 2Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Feb 2009
- Primary completion
- Dec 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in Gastric carcinoma (GC), sponsored by Chinese PLA General Hospital. Started Feb 2009; status: completed.
02
Drugs
bevacizumab
03
Conditions
Gastric carcinoma (GC)
Beyond the preview
Go deeper on NCT02048540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02048540.